RIPK1 and Parkinson disease: Based on these findings, we suggest that the NRDEGs CFLAR, RIPK1, TRADD, poly (ADP-ribose) polymerase 1, CYLD, DNM1L, and IL1B may have strong influences on PD pathogenesis and thus could be potential targets for treatment.